FDA Import Alerts Explained: Removing Detained Products and Complying with Food Import Rules
FDA import alerts can stop shipments at the border and disrupt your operations. These alerts indicate potential violations that may…
Food & Drug Blog
FDA Label Review: Practical Steps to Prevent Misbranding Under FDA Labeling Requirements
Navigating FDA labeling rules can feel overwhelming for manufacturers and brand teams in the food and dietary supplement space. Because…
Responding to an FDA Warning Letter: Deadlines, Steps, and Practical Legal Strategy
Receiving an FDA warning letter is stressful and urgent for any company operating in regulated spaces. These letters point to…
FDA Dietary Supplement Claim Rules: Structure/Function, Health, and Disease Explained
The regulatory framework for dietary supplement claims is set by the FDA to protect consumers and promote truthful marketing. This…
What Are FDA Compliance Services? Understanding Scope, Process, and When to Hire an FDA Attorney
FDA compliance services help companies operating in food, drug, and cosmetic markets navigate federal rules and reduce regulatory risk. These…
FDA Compliance for Food, Dietary Supplements, Cosmetics, and OTC Drugs: Key Guidelines and Legal Support
Navigating FDA requirements is essential for companies that make or sell food, dietary supplements, cosmetics, or over-the-counter (OTC) drugs. Meeting…
FDA Halts Voluntary Cosmetic Registrations Amidst Overhauls
On March 27, 2023, the U.S. Food & Drug Administration (FDA) announced that it will no longer be accepting submissions…
Congress Increases Minimum Tobacco Sales Age to 21
On December 20, 2019, changes to the minimum tobacco-sale age were signed into law, increasing the federal minimum age for…
FDA Warns JUUL, Alleging Marketing Violations
On September 9, 2019, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to JUUL Labs, Inc. (JUUL),…
FDA Warning Letters for Alzheimer’s Supplement Claims
On February 11, 2019, the U.S. Food & Drug Administration (“FDA”) published a warning to the public entitled “FDA takes…